Summary and Conclusions
The case of an 18-year-old white man, suffering from chronic ulcerative colitis, is presented. Chloromycetin was one of the drugs used during the early part of the illness and is presumably the cause of aplastic anemia which was discovered postoperatively. Massive hemorrhage was the most prominent complication and apparently it was caused by the blood dyscrasia.
Rectal bleeding occurs commonly in ulcerative colitis, but massive and fatal hemorrhage is rare, occurring in 0.4 to 1.1 per cent of cases.
Chloromycetin therapy has been known to cause blood dyscrasias. In the management of chronic ulcerative colitis, where therapy is prolonged, the use of other chemotherapeutic agents, which have been proved to be more efficacious and safe, is recommended.
Similar content being viewed by others
References
Bacon, H. E.: Ulcerative Colitis. Philadelphia, J. B. Lippincott Company, 1958, p. 124.
Banks, B. M., B. I. Korelitz and L. Zetzel: The course of nonspecific ulcerative colitis: Review of twenty years’ experience and late results. Gastroenterology.32: 983, 1957.
Bercovitz, Z. T.: Symposium on diseases of colon: Chloromycetin therapy of chronic ulcerative colitis — one-year study. Gastroenterology.16: 19, 1950.
Cable, J. V. and J. D. Reid: Jaundice and aplastic anaemia following chloramphenicol therapy. New Zealand M. J.56: 532, 1957.
Kautz, H. D. and N. de Nosaquo: Blood dyscrasias associated with chloramphenicol (chloromycetin) therapy. J.A.M.A.172: 2044, 1960.
Kringelbach, J.: Aplastisk anaemi efter chloromycetinbehandling af kighoste. Ugesk. laeger.120: 913, 1958.
Louwette, R. and A. Lambrechts: La toxicite sanguine du chloramphenicol. Rev. méd. Liége.12: 10, 1957.
Madsen, N. O.: Anaemia aplastica frem-kaldt af chloramphenicol. Ugesk. laeger.119: 489, 1957.
Ozer, F. L., W. E. Traux and W. C. Levin: Erythroid hypoplasia associated with chloramphenicol therapy. Blood.16: 997, 1960.
Page, R. C. and Z. Bercovitz: Prothrombin and fibrinogen studies in chronic ulcerative colitis. Am. J. Digest. Dis.9: 419, 1942.
Parke-Davis Sued Again on Charges Its Drug Caused Death of Youth. The Wall Street Journal, Thursday, January 5, 1961.
Perillie, P. E. and R. Nagler: Development of pernicious anemia in a young patient with chronic ulcerative colitis: Report of a case. New England J. Med.261: 1175, 1959.
Poulton, E. M.: Thrombocytopenic purpura during chloramphenicol therapy. Brit. M. J.2: 106, 1955.
Rankin, F. W., J. A. Bargen and L. A. Buie: The Colon, Rectum and Anus. Philadelphia, W. B. Saunders Company, 1932, p. 237.
Ricketts, W. E. and W. L. Palmer: Complications of chronic non-specific ulcerative colitis. Gastroenterology.7: 55, 1946.
Salamone, L.: Sull’emopatia da CAF. Riforma med.71: 494, 1957.
Shaw, R. G. and J. A. McLean: Chloramphenicol and aplastic anaemia. Australia M. J.1: 352, 1957.
Sloan, W. P., Jr., J. A. Bargen and R. P. Gage: Symposium on diseases of colon: Life histories of patients with chronic ulcerative colitis: Review of 2,000 cases. Gastroenterology.16: 25, 1950.
Sollmann, Torald H.: A Manual of Pharmacology and Its Applications to Therapeutics and Toxicology. Ed. 8, Philadelphia, W. B. Saunders Company, 1957, p. 800.
Visconti, P.: Sualla mielosi aplastica globale da cloramfenicolo: Contributo clinico. Riforma med.70: 1043, 1956.
Welch, H., C. N. Lewis, H. I. Weinstein and B. B. Boeckman: Severe reactions to antibiotics: A nationwide survey. Antibiotics & Chemother.4: 800, 1957.
Author information
Authors and Affiliations
Additional information
Read at the meeting of the Pennsylvania Proctologic Society, March 1, 1961.
About this article
Cite this article
Nuguid, T.P., Bacon, H.E. Aplastic anemia following chloramphenicol therapy in chronic ulcerative colitis. Dis Colon Rectum 4, 269–274 (1961). https://doi.org/10.1007/BF02616604
Issue Date:
DOI: https://doi.org/10.1007/BF02616604